Mount Sinai, NASA and Space Tango just launched living mini hearts and brains to the ISS to study aging and protect future astronauts.
Living miniature organs left Cape Canaveral Space Force Station in Florida on Tuesday morning, bound for the International Space Station on commercial resupply mission CRS-35. ABC News reported the shipment marks the first time these lab-grown organs have gone into space, in a joint push by Mount Sinai researchers, NASA, and aerospace firm Space Tango.
The cargo is expected to reach the station on Thursday. Once there, the tissue will face the same radiation and near-zero gravity that stress real astronauts, and that may speed up aging in ways doctors can measure.
That dual purpose sits at the center of the project. Officials want safer long-duration flights as America prepares to return to the moon and look farther out. They also want a faster way to study heart decline, brain disease, and the damage that comes from long stretches of bed rest on Earth.
Researchers packed up to 16 miniature hearts for the flight, along with miBrains, tiny brain models about the size of a peppercorn, built to mimic both healthy and diseased tissue. The organs ride inside a Space Tango CubeLab, a compact automated chamber designed to recreate conditions closer to the human body.
Gentry Barnett, chief technology officer at Space Tango, described the hardware in plain terms.
"[It is] slightly bigger than a shoebox, and it is a fully automated, miniaturized system."
Kevin Costa, an associate professor of surgery at the Icahn School of Medicine at Mount Sinai, is among the scientists sending the hearts aloft. The plan is to test how the tissue answers electrical signals and how it holds up in near-zero gravity, the same environment astronauts live in for months at a time.
Costa put the aging stakes in hard numbers.
"Six months in space... is equivalent to about 10 to 20 years of aging on Earth."
If that comparison holds under closer study, a short station stay becomes a compressed window on problems that normally take decades to unfold on the ground.
This flight builds on earlier work. In 2023, Mount Sinai’s Cardiovascular Research Institute sent individual heart cells to the ISS and confirmed they could survive in weightlessness. The new mission scales that idea up from loose cells to structured mini organs that beat and respond more like real tissue.
David Sachs, an assistant professor of surgery at the Icahn School of Medicine at Mount Sinai, framed the work as both an exploration problem and a medical one.
"If people are going to be living and working in space, then we need to understand what's going to happen to them."
He added a second motive that reaches far beyond the station.
"But also, because it's interesting as a model of accelerated aging for studying people on Earth."
Sachs has also pointed to microgravity as a stand-in for long sedentary stretches and bed rest, conditions that weaken muscle, bone, and circulation in ordinary patients, not only crew members.
The miBrains come from work tied to Joel Blanchard, an associate professor of stem cell biology, regenerative medicine, and neuroscience at the Icahn School of Medicine at Mount Sinai. His lab’s models are meant to show how mini-brains react once radiation and weightlessness hit.
Blanchard said the payoff is not limited to flight medicine.
"[The research is] translating to stuff in space, but it's also translating back to the research we do in the laboratory to help people with Parkinson's and Alzheimer's disease."
That is the practical test for taxpayers and families. If orbit reveals damage pathways doctors cannot easily see on Earth, the same data can sharpen lab work on diseases that already strain hospitals, caregivers, and public budgets.
Lisa Carnell, director of NASA’s biological and physical sciences division, cast the experiments as more than a station hobby. She said the work is a starting point for research beyond low Earth orbit, as the agency plans to put astronauts back on the moon’s surface in 2028, build a permanent lunar base in the next decade, and keep talking with SpaceX about crewed trips to Mars.
Carnell linked today’s tools to the gap left by earlier eras of exploration.
"We sent Apollo astronauts out there over 50 years ago, but the techniques and the way that we can actually do assessments to understand what's happening has come a long way since then."
She went further on what microgravity and space radiation can show that ground labs cannot.
"We're making leaps, not incremental research, by taking biology to space, because you're seeing changes that you cannot see on the ground in ways you've never seen it before."
In other words, the station is not just a destination. It is a stress test the Earth cannot fully copy.
The lineup matters. Mount Sinai supplies the biology. NASA supplies the flight medicine mandate and the exploration calendar. Space Tango supplies the automated CubeLab that keeps the tissue alive without constant crew babysitting. Commercial resupply gets the box off the pad at Cape Canaveral and onto the station.
That is a public-private chain aimed at concrete questions: How fast do heart tissues weaken? How do brain models change? What does months of weightlessness do that years of ordinary aging also do? And what can crews, and patients on the ground, do about it?
Open details remain. The ABC News account gives relative launch and arrival days rather than a full public mission clock, and it does not spell out exact sample counts for every brain model or the full recovery timeline after the tissue returns. The aging-equivalence claim comes from the researchers’ framing in that report, not from a separate dataset laid out in the same piece.
Even so, the direction is plain. America is no longer limited to sending a few cells and hoping they survive. It is sending structured mini organs, watching them under real space stress, and asking whether the same signals can protect astronauts on the way to the moon, and help people fighting Parkinson’s, Alzheimer’s, and the slow wear of inactive life back home.
Serious spaceflight demands serious biology. When U.S. labs, NASA, and private flight tech pull in the same direction, the country gets answers faster, in orbit and in the clinic.
